PillRx only · Suspension · Oral
Acyclovir
Acyclovir
9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US11 NDCs
9 active makers
9 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.064
Latest avg · Jul 22, 2026
-21%
Since Dec 17, 2025
9
Active US suppliers
50%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
28K
Rx · 2026 Q1
6.4M
Units dispensed
-9%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it9 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| ATLANTIC BIOLOGICALS CORP. | unknown | 5 | SUPPLYING |
| Chartwell RX, LLC | unknown | 3 | SUPPLYING |
| Chartwell Governmental & Specialty RX, LLC. | unknown | 2 | SUPPLYING |
| Aurobindo Pharma Limited | unknown | 1 | SUPPLYING |
| Advagen Pharma Ltd | unknown | 1 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | unknown | 1 | SUPPLYING |
| ANI Pharmaceuticals, Inc. | unknown | 1 | SUPPLYING |
| Novadoz Pharmaceuticals LLC | unknown | 1 | SUPPLYING |
| Actavis Pharma, Inc. | unknown | 1 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.